Literature DB >> 9428345

Brain tumor cell invasion, anatomical and biological considerations.

F Thorsen1, B B Tysnes.   

Abstract

Gliomas exhibit diffuse infiltration into the normal brain parenchyma, and the tumor cells often show morphological features similar to reactive glia cells, making it difficult to discriminate tumor cells from other neural cell populations both in vitro and in vivo. Several methods have therefore been developed in order to observe migrating tumor cells in experimental tumor models. These include labeling of tumor cells with vital dyes as well as by using genetic markers. Despite the fact that these malignancies are highly invasive in the brain, they rarely metastazise out of the central nervous system (CNS). The dissemination of tumor cells is probably mediated both by passive cell displacement and by active cell migration. Tumor cells may be displaced within the brain by the passive flow of cerebrospinal fluid (CSF) within the perivascular space and along ventricular linings. Tumor growth and invasion occur in a micromillieu that is regulated both by cancer cells and normal cells. The biological attributes of invasion and cell migration include cell adhesion to extracellular matrix components, cell locomotion, and the ability to create space into which to move. This process is characterized by the degradation and turnover of ECM components, which implies the production of specific proteases and inhibitors. Tumor progression is also influenced by numerous growth factors which may stimulate the malignant cells both by paracrine and autocrine mechanisms. Tumor growth requires the persistent formation of new blood vessels and the induction of angiogenesis is most likely occurring during early stages of tumor development. This process is regulated both by several inducers and inhibitors of endothelial cell proliferation and migration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9428345

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

Review 1.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 2.  Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.

Authors:  Niyanta N Kumar; Michelle E Pizzo; Geetika Nehra; Brynna Wilken-Resman; Sam Boroumand; Robert G Thorne
Journal:  Bioconjug Chem       Date:  2018-10-24       Impact factor: 4.774

3.  Human glioblastoma biopsy spheroids xenografted into the nude rat brain show growth inhibition after stereotactic radiosurgery.

Authors:  Frits Thorsen; Per Øyvind Enger; Jian Wang; Rolf Bjerkvig; Paal-Henning Pedersen
Journal:  J Neurooncol       Date:  2006-09-06       Impact factor: 4.130

Review 4.  Antiangiogenic therapy in brain tumor models.

Authors:  H J Bernsen; A J van der Kogel
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

5.  Effects of radiation on a model of malignant glioma invasion.

Authors:  G S Bauman; W MacDonald; E Moore; D A Ramsey; B J Fisher; V R Amberger; R M Del Maestro
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

6.  Midline glioblastoma multiforme with bilateral symmetric cysts.

Authors:  Hai-Ong Lee; Eun-Jeong Koh; Young-Min Oh; Ha-Young Choi
Journal:  J Korean Neurosurg Soc       Date:  2008-02-20

Review 7.  Adenoviral virotherapy for malignant brain tumors.

Authors:  Suvobroto Nandi; Maciej S Lesniak
Journal:  Expert Opin Biol Ther       Date:  2009-06       Impact factor: 4.388

8.  Tyrosine-dependent basolateral targeting of human connexin43-eYFP in Madin-Darby canine kidney cells can be disrupted by the oculodentodigital dysplasia mutation L90V.

Authors:  Jana Chtchetinin; Wes D Gifford; Sichen Li; William A Paznekas; Ethylin Wang Jabs; Albert Lai
Journal:  FEBS J       Date:  2009-10-27       Impact factor: 5.542

9.  Reduced glioma infiltration in Src-deficient mice.

Authors:  Caren V Lund; Mai T N Nguyen; Geoffrey C Owens; Andrew J Pakchoian; Ashkaun Shaterian; Carol A Kruse; Brian P Eliceiri
Journal:  J Neurooncol       Date:  2006-03-22       Impact factor: 4.130

10.  Establishment of atypical-teratoid/rhabdoid tumor (AT/RT) cell cultures from disseminated CSF cells: a model to elucidate biology and potential targeted therapeutics.

Authors:  Aru Narendran; Lucas Coppes; Aarthi Jayanthan; Michael Coppes; Bijan Teja; Delphine Bernoux; David George; Douglas Strother
Journal:  J Neurooncol       Date:  2008-07-24       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.